Biotech Law

The biotech company also put up defenses like a shareholder … would leave the show. Several securities law experts say the delay in the BlackBerry 10, and overly optimistic remarks by Research in Motion’s chief executive, may make the …

have inserted key language, via corrupt legislators of course, that will dismantle existing federal law as it pertains to regulating GM crops, and replace it with a free-for-all system where biotech giants are basically free to grow and market whatever … Continue reading →

Wiggin and Dana was also recognized among a select group of eleven law firms in the area of Licensing and Collaboration. For three decades the attorneys in the Wiggin and Dana Biotechnology and Life Sciences Practice Group have served as … Continue reading →

Signed into law this week, the GAIN Act provides incentives for … About PolyMedix, Inc. PolyMedix is a clinical stage biotechnology company developing a novel class of antimicrobial agents – cidins, small-molecule mimetics of host-defense …

“BIO will continue to work with relevant federal and state agencies to ensure implementation of the law in a manner that helps enable the U.S. biotech community’s continued development of lifesaving cures and other medical breakthroughs while expanding …

Legal firm Osborne Clarke acted as Grifols’ advisors and Rousaud … As a Grifols investment vehicle it currently owns shares of Nanotherapix (51% equity share), Araclon Biotech (51% equity share), and now of VCN Biosciences (40% equity share).

Here he again corrects Judge Moore’s statements regarding the utility of isolated DNA for use as primers and probes, correctly stating that “the single most important category of biotechnology products” have been therapeutic proteins like erythropoietin …

was instrumental in generating more than $2 billion in profit from Icahn’s biotech investments. Ninivaggi received a Master of Business Administration from the University of Chicago and a law degree from Stanford University. Forest claims that Ende …

“The regulator’s only job is to look at safety and efficacy of drugs, and it is not obliged to look at validity of patents,” said Shamnad Basheer, professor in Intellectual Property Law, National University of Judicial Sciences.

Combined, if passed into law, the two bills would effectively negate any semblance of public oversight of new GMO crops. And that’s not all the goodies for biotech lodged in the House ag committee’s bill. It also requires the USDA … Continue reading →